Down-regulation of fragile histidine triad expression in prostate carcinoma
Open Access
- 3 March 2003
- Vol. 97 (6) , 1447-1452
- https://doi.org/10.1002/cncr.11201
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Expression of Group IIA Secretory Phospholipase A2 Is Elevated in Prostatic Intraepithelial Neoplasia and AdenocarcinomaThe American Journal of Pathology, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Successful Treatment of Primary and Disseminated Human Lung Cancers by Systemic Delivery of Tumor Suppressor Genes Using an Improved Liposome VectorMolecular Therapy, 2001
- Frequent Altered Expression of Fragile Histidine Triad Protein in Human Colorectal AdenomasBiochemical and Biophysical Research Communications, 2000
- Loss of FHIT Expression in Transitional Cell Carcinoma of the Urinary BladderThe American Journal of Pathology, 2000
- THE ROLE OF THE FHIT/FRA3B LOCUS IN CANCERAnnual Review of Genetics, 1998
- Molecular analysis of the FHIT gene in human prostate cancerOncogene, 1998
- A 350-kb Cosmid Contig in 3p14.2 That Crosses the t(3;8) Hereditary Renal Cell Carcinoma Translocation Breakpoint and 17 Aphidicolin-Induced FRA3B BreakpointsGenomics, 1996
- Involvement of band 3p14 in t(3;8) hereditary renal carcinomaCancer Genetics and Cytogenetics, 1984
- Hereditary Renal-Cell Carcinoma Associated with a Chromosomal TranslocationNew England Journal of Medicine, 1979